{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:30:37Z","timestamp":1780439437210,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The Covid-19 pandemic is causing changes in delivery of medical care worldwide. It is not known how the management of headache patients was affected by the lockdown during the pandemic. The aim of the present study was to investigate how the initial phase of the Covid-19 pandemic affected the hospital management of headache in Denmark and Norway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All neurological departments in Denmark (<jats:italic>n<\/jats:italic>\u2009=\u200914) and Norway (<jats:italic>n<\/jats:italic>\u2009=\u200918) were invited to a questionnaire survey. The study focused on the lockdown and all questions were answered in regard to the period between March 12th and April 15th, 2020.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The responder rate was 91% (29\/32). Of the neurological departments 86% changed their headache practice during the lockdown. The most common change was a shift to more telephone consultations (86%). Video consultations were offered by 45%.<\/jats:p><jats:p>The number of new headache referrals decreased. Only 36% administered botulinum toxin A treatment according to usual schemes. Sixty% reported that fewer patients were admitted for in-hospital emergency diagnostics and treatment. Among departments conducting headache research 57% had to halt ongoing projects. Overall, 54% reported that the standard of care was worse for headache patients during the pandemic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Hospital-based headache care and research was impacted in Denmark and Norway during the initial phase of the Covid-19-pandemic.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s10194-020-01195-2","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T13:03:09Z","timestamp":1603976589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Hospital-based headache care during the Covid-19 pandemic in Denmark and Norway"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8999-5424","authenticated-orcid":false,"given":"Espen Saxhaug","family":"Kristoffersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif Waqar","family":"Faiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else Charlotte","family":"Sandset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette Margrethe","family":"Storstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Stefansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bendik Slagsvold","family":"Winsvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob M\u00f8ller","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"issue":"10224","key":"1195_CR1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(20)30374-3","volume":"395","author":"DL Heymann","year":"2020","unstructured":"Heymann DL, Shindo N (2020) COVID-19: what is next for public health? Lancet 395(10224):542\u2013545","journal-title":"Lancet"},{"issue":"24","key":"1195_CR2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/WNL.0000000000009677","volume":"94","author":"SN Grossman","year":"2020","unstructured":"Grossman SN, Han SC, Balcer LJ, Kurzweil A, Weinberg H, Galetta SL et al (2020) Rapid implementation of virtual neurology in response to the COVID-19 pandemic. Neurology. 94(24):1077\u20131087","journal-title":"Neurology."},{"issue":"5","key":"1195_CR3","volume":"22","author":"Z Hong","year":"2020","unstructured":"Hong Z, Li N, Li D, Li J, Li B, Xiong W et al (2020) Telemedicine during the COVID-19 pandemic: experiences from Western China. J Med Internet Res 22(5):e19577","journal-title":"J Med Internet Res"},{"issue":"7","key":"1195_CR4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/jamia\/ocaa072","volume":"27","author":"DM Mann","year":"2020","unstructured":"Mann DM, Chen J, Chunara R, Testa PA, Nov O (2020) COVID-19 transforms health care through telemedicine: evidence from the field. J Am Med Inform Assoc 27(7):1132\u20131135","journal-title":"J Am Med Inform Assoc"},{"key":"1195_CR5","doi-asserted-by":"crossref","first-page":"116930","DOI":"10.1016\/j.jns.2020.116930","volume":"414","author":"B Roy","year":"2020","unstructured":"Roy B, Nowak RJ, Roda R, Khokhar B, Patwa HS, Lloyd T et al (2020) Teleneurology during the COVID-19 pandemic: a step forward in modernizing medical care. J Neurol Sci 414:116930","journal-title":"J Neurol Sci"},{"issue":"5","key":"1195_CR6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/head.13810","volume":"60","author":"CL Szperka","year":"2020","unstructured":"Szperka CL, Ailani J, Barmherzig R, Klein BC, Minen MT, Halker Singh RB et al (2020) Migraine Care in the era of COVID-19: clinical pearls and Plea to insurers. Headache. 60(5):833\u2013842","journal-title":"Headache."},{"issue":"1","key":"1195_CR7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s10194-020-01106-5","volume":"21","author":"A MaassenVanDenBrink","year":"2020","unstructured":"MaassenVanDenBrink A, de Vries T, Danser AHJ (2020) Headache medication and the COVID-19 pandemic. J Headache Pain. 21(1):38","journal-title":"J Headache Pain."},{"issue":"8","key":"1195_CR8","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/head.13903","volume":"60","author":"KN Arca","year":"2020","unstructured":"Arca KN, Smith JH, Chiang C-C, Starling AJ, Robertson CE, Halker Singh RB et al (2020) COVID-19 and headache medicine: a narrative review of non-steroidal anti-inflammatory drug (NSAID) and corticosteroid use. Headache. 60(8):1558\u20131568","journal-title":"Headache."},{"issue":"6","key":"1195_CR9","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/head.13830","volume":"60","author":"A Ali","year":"2020","unstructured":"Ali A (2020) Delay in OnabotulinumtoxinA treatment during the COVID-19 pandemic-perspectives from a virus hotspot. Headache. 60(6):1183\u20131186","journal-title":"Headache."},{"issue":"5","key":"1195_CR10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/head.13803","volume":"60","author":"M Silvestro","year":"2020","unstructured":"Silvestro M, Tessitore A, Tedeschi G, Russo A (2020) Migraine in the time of COVID-19. Headache. 60(5):988\u2013989","journal-title":"Headache."},{"key":"1195_CR11","doi-asserted-by":"crossref","first-page":"m1401","DOI":"10.1136\/bmj.m1401","volume":"369","author":"J Thornton","year":"2020","unstructured":"Thornton J (2020) Covid-19: a&E visits in England fall by 25% in week after lockdown. BMJ. 369:m1401","journal-title":"BMJ."},{"key":"1195_CR12","doi-asserted-by":"crossref","unstructured":"Butt JH, Fosb\u00f8l EL, \u00d8stergaard L, Yafasova A, Andersson C, Schou M et al (2020) The Impact of Coronavirus Disease 2019 (COVID-19) on First-time Acute Stroke and Transient Ischemic Attack Admission Rates and Prognosis in Denmark: A Nationwide Cohort Study. Circulation Epub ahead of print","DOI":"10.1161\/CIRCULATIONAHA.120.050173"},{"key":"1195_CR13","doi-asserted-by":"crossref","unstructured":"Kristoffersen ES, Jahr SH, Thommessen B, R\u00f8nning OM (2020) Effect of COVID-19 pandemic on stroke admission rates in a Norwegian population. Acta Neurol Scand Epub ahead of print","DOI":"10.1111\/ane.13307"},{"issue":"3","key":"1195_CR14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/WNL.0000000000006697","volume":"92","author":"TP Do","year":"2019","unstructured":"Do TP, Remmers A, Schytz HW, Schankin C, Nelson SE, Obermann M et al (2019) Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology. 92(3):134\u2013144","journal-title":"Neurology."},{"key":"1195_CR15","doi-asserted-by":"crossref","unstructured":"Kaur N, Gupta I, Singh H, Karia R, Ashraf A, Habib A et al (2020) Epidemiological and clinical characteristics of 6635 COVID-19 patients: a pooled analysis. SN Compr Clin Med:1\u20135. Epub ahead of print","DOI":"10.1007\/s42399-020-00393-y"},{"key":"1195_CR16","doi-asserted-by":"crossref","unstructured":"Padda I, Khehra N, Jaferi U, Parmar MS (2020) The neurological complexities and prognosis of COVID-19. SN Compr Clin Med:1\u201312. Epub ahead of print","DOI":"10.1007\/s42399-020-00527-2"},{"key":"1195_CR17","doi-asserted-by":"crossref","unstructured":"Bergquist SH, Partin C, Roberts DL, O'Keefe JB, Tong EJ, Zreloff J et al (2020) Non-hospitalized adults with COVID-19 differ noticeably from hospitalized adults in their demographic, clinical, and social characteristics. SN Compr Clin Med:1\u20139. Epub ahead of print","DOI":"10.1007\/s42399-020-00453-3"},{"issue":"1","key":"1195_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s10194-020-01188-1","volume":"21","author":"\u00d6 Uygun","year":"2020","unstructured":"Uygun \u00d6, Erta\u015f M, Ekizo\u011flu E, Bolay H, \u00d6zge A, Kocasoy Orhan E et al (2020) Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain 21(1):121","journal-title":"J Headache Pain"},{"issue":"1","key":"1195_CR19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s10194-020-01165-8","volume":"21","author":"J Trigo","year":"2020","unstructured":"Trigo J, Garc\u00eda-Azor\u00edn D, Planchuelo-G\u00f3mez \u00c1, Mart\u00ednez-P\u00edas E, Talavera B, Hern\u00e1ndez-P\u00e9rez I et al (2020) Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study. J Headache Pain 21(1):94","journal-title":"J Headache Pain"},{"issue":"1","key":"1195_CR20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(17)30405-2","volume":"17","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, May A (2018) Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol 17(1):75\u201383","journal-title":"Lancet Neurol"},{"issue":"3","key":"1195_CR21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jnnp.2005.073221","volume":"77","author":"R Latinovic","year":"2006","unstructured":"Latinovic R, Gulliford M, Ridsdale L (2006) Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry 77(3):385\u2013387","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"538","key":"1195_CR22","first-page":"388","volume":"57","author":"L Ridsdale","year":"2007","unstructured":"Ridsdale L, Clark LV, Dowson AJ, Goldstein LH, Jenkins L, McCrone P et al (2007) How do patients referred to neurologists for headache differ from those managed in primary care? Br J Gen Pract 57(538):388\u2013395","journal-title":"Br J Gen Pract"},{"issue":"2","key":"1195_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10194-011-0391-8","volume":"13","author":"ES Kristoffersen","year":"2012","unstructured":"Kristoffersen ES, Grande RB, Aaseth K, Lundqvist C, Russell MB (2012) Management of primary chronic headache in the general population: the Akershus study of chronic headache. J Headache Pain 13(2):113\u2013120","journal-title":"J Headache Pain"},{"issue":"5","key":"1195_CR24","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.5221","volume":"18","author":"KI M\u00fcller","year":"2016","unstructured":"M\u00fcller KI, Alstadhaug KB, Bekkelund SI (2016) Acceptability, feasibility, and cost of telemedicine for nonacute headaches: a randomized study comparing video and traditional consultations. J Med Internet Res 18(5):e140","journal-title":"J Med Internet Res"},{"key":"1195_CR25","doi-asserted-by":"crossref","unstructured":"Begasse de Dhaem O, Bernstein C (2020) Headache Virtual Visit Toolbox: The Transition From Bedside Manners to Webside Manners. Headache Epub ahead of print","DOI":"10.1111\/head.13885"},{"issue":"12","key":"1195_CR26","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1177\/0333102419868250","volume":"39","author":"DI Friedman","year":"2019","unstructured":"Friedman DI, Rajan B, Seidmann A (2019) A randomized trial of telemedicine for migraine management. Cephalalgia. 39(12):1577\u20131585","journal-title":"Cephalalgia."},{"issue":"2","key":"1195_CR27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1212\/WNL.0000000000004085","volume":"89","author":"KI M\u00fcller","year":"2017","unstructured":"M\u00fcller KI, Alstadhaug KB, Bekkelund SI (2017) A randomized trial of telemedicine efficacy and safety for nonacute headaches. Neurology. 89(2):153\u2013162","journal-title":"Neurology."},{"issue":"6","key":"1195_CR28","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","volume":"50","author":"DW Dodick","year":"2010","unstructured":"Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50(6):921\u2013936","journal-title":"Headache"},{"issue":"4","key":"1195_CR29","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/jech-2018-211127","volume":"73","author":"ES Kristoffersen","year":"2019","unstructured":"Kristoffersen ES, Stavem K, Lundqvist C, Russell MB (2019) Impact of chronic headache on workdays, unemployment and disutility in the general population. J Epidemiol Community Health 73(4):360\u2013367","journal-title":"J Epidemiol Community Health"},{"issue":"4","key":"1195_CR30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1474-4422(08)70062-0","volume":"7","author":"R Jensen","year":"2008","unstructured":"Jensen R, Stovner LJ (2008) Epidemiology and comorbidity of headache. Lancet Neurol 7(4):354\u2013361","journal-title":"Lancet Neurol"},{"issue":"5","key":"1195_CR31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/ane.12751","volume":"136","author":"S Ashina","year":"2017","unstructured":"Ashina S, Bendtsen L, Buse DC, Lyngberg AC, Lipton RB, Jensen R (2017) Neuroticism, depression and pain perception in migraine and tension-type headache. Acta Neurol Scand 136(5):470\u2013476","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"1195_CR32","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jnnp.2009.192492","volume":"81","author":"DC Buse","year":"2010","unstructured":"Buse DC, Manack A, Serrano D, Turkel C, Lipton RB (2010) Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 81(4):428\u2013432","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1195_CR33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s10194-020-01168-5","volume":"21","author":"M Ma","year":"2020","unstructured":"Ma M, Fang J, Li C, Bao J, Zhang Y, Chen N et al (2020) The status and high risk factors of severe psychological distress in migraine patients during nCOV-2019 outbreak in Southwest China: a cross-sectional study. J Headache Pain 21(1):100","journal-title":"J Headache Pain"},{"issue":"1","key":"1195_CR34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s10194-020-01183-6","volume":"21","author":"JY Al-Hashel","year":"2020","unstructured":"Al-Hashel JY, Ismail II (2020) Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study. J Headache Pain 21(1):115","journal-title":"J Headache Pain"},{"key":"1195_CR35","doi-asserted-by":"crossref","unstructured":"Leonardi M, Lee H, van der Veen S, Maribo T, Cuenot M, Simon L et al (2020) Avoiding the banality of evil in times of COVID-19: thinking differently with a biopsychosocial perspective for future health and social policies development. SN Compr Clin Med:1\u20133","DOI":"10.1007\/s42399-020-00486-8"},{"issue":"5","key":"1195_CR36","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/head.13821","volume":"60","author":"RE Wells","year":"2020","unstructured":"Wells RE, Strauss LD (2020) The value of headache-specific recommendations during COVID-19. Headache. 60(5):820\u2013823","journal-title":"Headache."},{"key":"1195_CR37","volume-title":"Daily report and statistics about coronavirus and COVID-19","author":"Norwegian Institute of Public Health","year":"2020","unstructured":"Norwegian Institute of Public Health. Daily report and statistics about coronavirus and COVID-19 2020 [Available from: https:\/\/www.fhi.no\/en\/id\/infectious-diseases\/coronavirus\/daily-reports\/daily-reports-COVID19\/"}],"updated-by":[{"DOI":"10.1186\/s10194-020-01199-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000}}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-020-01195-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10194-020-01195-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-020-01195-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T07:12:46Z","timestamp":1618125166000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-020-01195-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1195"],"URL":"https:\/\/doi.org\/10.1186\/s10194-020-01195-2","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s10194-020-01199-y","asserted-by":"object"}]},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,29]]},"assertion":[{"value":"9 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via the original article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Data Protection Officer at Akershus University Hospital (Norway) approved the study. The study (NorPan) was registered in the Covid-19 trial registration at the Norwegian Clinical Research Infrastructure Network. No ethical approval was deemed necessary because no patient data were used.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BWS has received speaking fees from Novartis, unrelated to the present work. ECS has received speaking fees from Bayer and Novartis, unrelated to the present work. JMH has received speaking fees for TEVA and Novartis. AMS, ESK, KWF and SS report no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}